Get the Stockscreener App
12.55
0.32%
-0.04
Mind Medicine Inc stock is traded at $12.55, with a volume of 1.18M.
It is down -0.32% in the last 24 hours and up +3.38% over the past month.
Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).
See More
Previous Close:
$12.59
Open:
$12.94
24h Volume:
1.18M
Relative Volume:
0.63
Market Cap:
$1.24B
Revenue:
$11.40B
Net Income/Loss:
$-95.73M
P/E Ratio:
-5.1224
EPS:
-2.45
Net Cash Flow:
$-64.37M
1W Performance:
+1.62%
1M Performance:
+3.38%
6M Performance:
+71.92%
1Y Performance:
+78.77%
1-Day Range:
$12.29
$13.02
1-Week Range:
$12.19
$13.45
52-Week Range:
$4.70
$14.43
Mind Medicine Inc Stock (MNMD) Company Profile
Name
Mind Medicine Inc
Sector
Industry
Phone
212-220-6633
Address
ONE WORLD TRADE CENTER, NEW YORK
Compare MNMD with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MNMD
Mind Medicine Inc
|
12.55 | 1.24B | 11.40B | -95.73M | -64.37M | -2.45 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Mind Medicine Inc Stock (MNMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-13-25 | Initiated | Needham | Buy |
| Aug-04-25 | Resumed | Oppenheimer | Outperform |
| Jan-28-25 | Initiated | Evercore ISI | Outperform |
| Dec-20-24 | Initiated | Chardan Capital Markets | Buy |
| Oct-14-24 | Resumed | Leerink Partners | Outperform |
| Jul-24-24 | Initiated | ROTH MKM | Buy |
| May-29-24 | Initiated | Robert W. Baird | Outperform |
| Apr-15-24 | Initiated | Leerink Partners | Outperform |
| Dec-05-23 | Initiated | Canaccord Genuity | Buy |
| Dec-09-22 | Resumed | ROTH Capital | Buy |
| Nov-16-22 | Initiated | RBC Capital Mkts | Outperform |
| Aug-26-22 | Initiated | Oppenheimer | Outperform |
| Aug-10-22 | Initiated | Cantor Fitzgerald | Overweight |
| May-04-22 | Initiated | ROTH Capital | Buy |
| Jun-28-21 | Initiated | Maxim Group | Buy |
View All
Mind Medicine Inc Stock (MNMD) Latest News
Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Down 4.6%Here's Why - MarketBeat
Marshall Wace LLP Has $22.20 Million Holdings in Mind Medicine (MindMed) Inc. $MNMD - MarketBeat
MindMed stock soars 73% after InvestingPro’s undervalued call in May 2024 By Investing.com - Investing.com UK
Mind Medicine (MindMed) (NASDAQ:MNMD) Shares Up 6.2%What's Next? - MarketBeat
Is Mind Medicine (MindMed) Inc. (MMQ) stock undervalued after correctionM&A Rumor & AI Forecasted Stock Moves - Newser
Discipline and Rules-Based Execution in MNMD Response - news.stocktradersdaily.com
Is Mind Medicine (MindMed) Inc. stock attractive for ETFs2025 Big Picture & Free Safe Capital Growth Stock Tips - Newser
MindMed Announces New Employee Inducement Grants - Business Wire
Mind Medicine Reports Q3 2025 Financial Results - MSN
Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Mind Medicine Inc (MMQ.DU) Stock Price, News, Quote & History - Yahoo! Finance Canada
Mind Medicine (MNMD) Reports Wider Loss and Major Equity Raise, How Will Capital Shape Its R&D Ambitions? - Sahm
Magic Mushroom Stocks List 2025: Best Companies to Trade - Bullish Bears
Mind Medicine (MindMed) Inc. (MMED.NE) Analyst insights, Price targets and Recommendations - Yahoo Finance UK
Mind Medicine stock soars after New Jersey advances psilocybin bill By Investing.com - Investing.com Australia
Mind Medicine stock soars after New Jersey advances psilocybin bill - Investing.com
Chardan Capital Upgrades Mind Medicine (MindMed) (NASDAQ:MNMD) to Strong-Buy - MarketBeat
Behavioral Patterns of MNMD and Institutional Flows - news.stocktradersdaily.com
Can Mind Medicine (MindMed) Inc. stock weather global recessionWeekly Volume Report & Weekly High Conviction Ideas - newser.com
How Mind Medicine (MindMed) Inc. stock reacts to Fed rate cutsForecast Cut & Expert Curated Trade Ideas - newser.com
How Mind Medicine (MindMed) Inc. (MMQ) stock compares with tech leaders2025 Volume Leaders & Advanced Swing Trade Entry Alerts - newser.com
How Mind Medicine (MindMed) Inc. stock performs in rising dollar environmentInsider Selling & Free Expert Verified Stock Movement Alerts - newser.com
Will Mind Medicine (MindMed) Inc. stock beat EPS estimatesJuly 2025 Trends & Target Return Focused Stock Picks - newser.com
Will Mind Medicine (MindMed) Inc. rebound enough to break evenFed Meeting & Technical Pattern Alert System - newser.com
Risk vs reward if holding onto Mind Medicine (MindMed) Inc.July 2025 Catalysts & Weekly Breakout Stock Alerts - newser.com
Can Mind Medicine (MindMed) Inc. stock outperform in 2025 bull marketStop Loss & Growth Focused Stock Pick Reports - newser.com
Mind Medicine Inc Stock (MNMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
Mind Medicine Inc Stock (MNMD) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Barrow Robert | Chief Executive Officer |
Sep 25 '25 |
Sale |
9.77 |
25,797 |
252,037 |
804,268 |
| Karlin Daniel | Chief Medical Officer |
Sep 25 '25 |
Sale |
9.77 |
7,704 |
75,268 |
430,625 |
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):